The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Implementing PAT for single-pass tangential flow ultrafiltration for continuous manufacturing of monoclonal antibodies
Abstract
Abstract Control of single pass tangential flow ultrafiltration is crucial for continuous manufacturing of monoclonal antibodies. We propose a strategy to control the output concentration of a continuous ultrafiltration step regardless of variations in the volume or concentration of the feed material. Scheduling algorithms for the filtration runs and cleaning cycles are developed, accounting for the expected cycle times of different unit operations in the continuous train. The complete design space for the membrane module is characterized experimentally. An empirical model of the design space is developed to predict the logarithmic relationship between the feed flowrate and the maximum concentration factors achievable in a single pass for feed concentrations in the range of 1–50 g/L and feed flowrates in the range of 10–210 mL/min. The control strategy leverages in-line concentration, flowrate and pressure sensors, including near infrared spectroscopy (NIRS) flow cells to measure the concentration of mAb in the feed and retentate streams in the range 0.5–200 g/L. The control elements are the permeate pump and a variable control valve on the retentate line, which are used to obtain the desired concentration factor across the module in a single pass. Two case studies are designed to test the control system under conditions of high feed flow rate and low feed concentration, and low feed flow rate and high feed concentration, respectively. Successful control is demonstrated in both cases. The proposed system is the first complete approach that integrates process understanding, advanced monitoring sensors, and control strategies to consistently achieve concentration targets over long continuous campaigns for production of monoclonal antibodies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“FT‐NIR has also been utilized for monitoring continuous processing, specifically for measuring the concentrations in feed and retentate streams during the UFDF step with single‐pass tangential flow filtration (SPTFF). By applying appropriate calibration models, accurate concentration predictions can be achieved, facilitating effective process control [65].”
From Current PAT Landscape in the Downstream Processing of Biopharmaceuticals (2025) · cites this paper as [65]
Citations
Cites
Thakur, G., Hebbi, V., & Rathore, A. S. (2020) · Biotechnology and Bioengineering · doi:10.1002/bit.27236 · Cited by 64
Self-citation
Research works printed but not linked: 29
- Kamerzell, 2011, Protein–excipient interactions: mechanisms and biophysical characterization applied to protein formulation development, Adv. Drug Deliv. Rev., 63, 1118, 10.1016/j.addr.2011.07.006 · DOI · Paper page
- Steele, 2014, Accounting for the Donnan effect in diafiltration optimization for high-concentration UFDF applications, BioProcess Int, 12, 50
- Baek, 2017, pH variations during diafiltration due to buffer nonidealities, Biotechnol. Prog., 33, 1555, 10.1002/btpr.2544 · doi:10.1002/btpr.2544
- Hebbi, 2020, Modeling and prediction of excipient and pH drifts during ultrafiltration/diafiltration of monoclonal antibody biotherapeutic for high concentration formulations, Separ. Purif. Technol., 238, 1, 10.1016/j.seppur.2019.116392 · DOI
- Hung, 2016, High concentration tangential flow ultrafiltration of stable monoclonal antibody solutions with low viscosities, J. Membr. Sci., 508, 113, 10.1016/j.memsci.2016.02.031 · DOI
- Rosenberg, 2009, Ultrafiltration concentration of monoclonal antibody solutions: development of an optimized method minimizing aggregation, J. Membr. Sci., 342, 50, 10.1016/j.memsci.2009.06.028 · DOI
- Schwartz, 2002, Introduction to tangential flow filtration for laboratory and process development applications, Pall Scientific & Technical Report, 33213
- Miao, 2009, Theoretical analysis of excipient concentrations during the final ultrafiltration/diafiltration step of therapeutic antibody, Biotechnol. Prog., 25, 964, 10.1002/btpr.168 · DOI
- Schwartz, 2003, Diafiltration for desalting or buffer exchange, BioProcess International, 1, 43
- Casey, 2011, Protein concentration with single-pass tangential flow filtration (SPTFF), J. Membr. Sci., 384, 82, 10.1016/j.memsci.2011.09.004 · DOI
- Nicholson, 2011, Single-use tangential flow filtration in bioprocessing, BioProcess International, 9, 38
- Paulen, 2011, Minimizing the process time for ultrafiltration/diafiltration under gel polarization conditions, J. Membr. Sci., 380, 148, 10.1016/j.memsci.2011.06.044 · doi:10.1016/j.memsci.2011.06.044
- Arunkumar, 2017, Investigation of single-pass tangential flow filtration (SPTFF) as an inline concentration step for cell culture harvest, J. Membr. Sci., 524, 20, 10.1016/j.memsci.2016.11.007 · doi:10.1016/j.memsci.2016.11.007
- Clutterbuck, 2017, Single-pass tangential flow filtration (SPTFF) in continuous biomanufacturing, Continuous Biomanufacturing: Innovative Technologies and Methods, 423
- Brinkmann, 2018, Leveraging single‐pass tangential flow filtration to enable decoupling of upstream and downstream monoclonal antibody processing, Biotechnol. Prog., 34, 405, 10.1002/btpr.2601 · DOI
- Rucker‐Pezzini, 2018, Single pass diafiltration integrated into a fully continuous mAb purification process, Biotechnol. Bioeng., 115, 1949, 10.1002/bit.26708 · doi:10.1002/bit.26708
- Elich, 2019, Investigating the combination of single‐pass tangential flow filtration and anion exchange chromatography for intensified mAb polishing, Biotechnol. Prog., 35, 10.1002/btpr.2862 · doi:10.1002/btpr.2862
- Huter, 2019, Model-based design and process optimization of continuous single pass tangential flow filtration focusing on continuous bioprocessing, Processes, 7, 317, 10.3390/pr7060317 · DOI
- Pollock, 2017, Integrated continuous bioprocessing: economic, operational, and environmental feasibility for clinical and commercial antibody manufacture, Biotechnol. Prog., 33, 854, 10.1002/btpr.2492 · DOI · Paper page
- Brestrich, 2018, Selective protein quantification for preparative chromatography using variable pathlength UV/Vis spectroscopy and partial least squares regression, Chem. Eng. Sci., 176, 157, 10.1016/j.ces.2017.10.030 · DOI
- Binabaji, 2015, Theoretical analysis of the ultrafiltration behavior of highly concentrated protein solutions, J. Membr. Sci., 494, 216, 10.1016/j.memsci.2015.07.068 · DOI
- Lu, 2007, Isolation of lactoferrin from bovine colostrum by ultrafiltration coupled with strong cation exchange chromatography on a production scale, J. Membr. Sci., 297, 152, 10.1016/j.memsci.2007.03.039 · DOI
- Thiess, 2017, Module design for ultrafiltration in biotechnology: hydraulic analysis and statistical modeling, J. Membr. Sci., 540, 440, 10.1016/j.memsci.2017.06.038 · doi:10.1016/j.memsci.2017.06.038
- van Reis, 2007, Bioprocess membrane technology, J. Membr. Sci., 297, 16, 10.1016/j.memsci.2007.02.045 · DOI · Paper page
- Glassey, 2011, Process analytical technology (PAT) for biopharmaceuticals, Biotechnol. J., 6, 369, 10.1002/biot.201000356 · DOI · Paper page
- Girard, 2015, Large-scale monoclonal antibody purification by continuous chromatography, from process design to scale-up, J. Biotechnol., 213, 65, 10.1016/j.jbiotec.2015.04.026 · DOI
- Ötes, 2017, Feasibility of using continuous chromatography in downstream processing: comparison of costs and product quality for a hybrid process vs. a conventional batch process, J. Biotechnol., 259, 213, 10.1016/j.jbiotec.2017.07.001 · doi:10.1016/j.jbiotec.2017.07.001
- Rathore, 2017, Continuous downstream processing for production of biotech therapeutics, Continuous Biomanufacturing: Innovative Technologies and Methods, 261
- Löfgren, 2019, Optimization of integrated chromatography sequences for purification of biopharmaceuticals, Biotechnol. Prog., 35, 10.1002/btpr.2871 · doi:10.1002/btpr.2871
Cited by
Helgers, H., Schmidt, A., Lohmann, L. J., Vetter, F. L., Juckers, A., Jensch, C., Mouellef, M., Zobel-Roos, S., & Strube, J. (2021) · Processes · doi:10.3390/pr9010172 · Cited by 52
Current PAT Landscape in the Downstream Processing of Biopharmaceuticals
Sathiyapriyan, P., Mukherjee, S., Vogel, T., Essen, L., Boerema, D., Vey, M., & Kalina, U. (2025) · Analytical Science Advances · doi:10.1002/ansa.70013 · Cited by 45
Continuous integrated manufacturing for biopharmaceuticals: A new paradigm or an empty promise?
Rathore, A. S., Thakur, G., & Kateja, N. (2023) · Biotechnology and Bioengineering · doi:10.1002/bit.28235 · Cited by 41
Self-citationVaskó, D., Pantea, E., Domján, J., Fehér, C., Mózner, O., Sarkadi, B., Nagy, Z. K., Marosi, G. J., & Hirsch, E. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.124251 · Cited by 12
Westwood, F., Ponstingl, M., & Dickens, J. E. (2024) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2024.115965 · Cited by 4
Metadata
- Authors
- Thakur, G., Thori, S., & Rathore, A. S.
- ORCID
- Rathore, Anurag S.
- Venue
- Journal of Membrane Science
- Publisher
- Elsevier BV
- Published
- 2020-11
- Volume
- 613
- Pages
- 118492
- ISSN
- 0376-7388
- Cited by
- 45
- References
- 1
- Language
- en
- Update notices
- erratum (2021-01-01)
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Funders
- Department of Science and Technology, Ministry of Science and Technology, India
- Tata Consultancy Services
- Department of Biotechnology, Ministry of Science and Technology, India
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Implementing PAT for single-pass tangential flow ultrafiltration for continuous manufacturing of monoclonal antibodies. https://app.cochat.ai/papers/10.1016/j.memsci.2020.118492
- The paper
- Thakur, G., Thori, S., & Rathore, A. S. (2020). Implementing PAT for single-pass tangential flow ultrafiltration for continuous manufacturing of monoclonal antibodies. Journal of Membrane Science. https://doi.org/10.1016/j.memsci.2020.118492
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.